0001209191-16-129048.txt : 20160621 0001209191-16-129048.hdr.sgml : 20160621 20160621163616 ACCESSION NUMBER: 0001209191-16-129048 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160617 FILED AS OF DATE: 20160621 DATE AS OF CHANGE: 20160621 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Juno Therapeutics, Inc. CENTRAL INDEX KEY: 0001594864 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 463656275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 307 WESTLAKE AVENUE NORTH, SUITE 300 CITY: SEATTLE STATE: WA ZIP: 98109 BUSINESS PHONE: 2066960703 MAIL ADDRESS: STREET 1: 307 WESTLAKE AVENUE NORTH, SUITE 300 CITY: SEATTLE STATE: WA ZIP: 98109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Levitsky Hyam CENTRAL INDEX KEY: 0001375792 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36781 FILM NUMBER: 161724755 MAIL ADDRESS: STREET 1: C/O ANTIGENICS INC. STREET 2: 162 FIFTH AVE., SUITE 900 CITY: NEW YORK STATE: NY ZIP: 10010 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-06-17 0 0001594864 Juno Therapeutics, Inc. JUNO 0001375792 Levitsky Hyam C/O 307 WESTLAKE AVENUE N STE 300 SEATTLE WA 98109 0 1 0 0 EVP, Research & CSO Common Stock 2016-06-17 4 S 0 12118 42.7563 D 117000 D Common Stock 2016-06-17 4 S 0 300 43.20 D 116700 D This transaction was executed in multiple trades at prices ranging from $42.195 to $43.18. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2016. /s/ Zachary Hale, attorney-in-fact 2016-06-21